Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (Diluted Average) (2019 - 2025)

Health Catalyst (HCAT) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $69.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 16.95% year-over-year to $69.5 million, compared with a TTM value of $69.5 million through Sep 2025, up 16.95%, and an annual FY2024 reading of $60.2 million, up 6.68% over the prior year.
  • Shares Outstanding (Diluted Average) was $69.5 million for Q3 2025 at Health Catalyst, roughly flat from $69.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $69.6 million in Q2 2025 and bottomed at $43.9 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $56.3 million, with a median of $56.0 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) increased 21.61% in 2021, then grew 4.27% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $47.5 million in 2021, then grew by 13.86% to $54.1 million in 2022, then rose by 4.32% to $56.4 million in 2023, then increased by 6.68% to $60.2 million in 2024, then increased by 15.52% to $69.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HCAT at $69.5 million in Q3 2025, $69.6 million in Q2 2025, and $68.6 million in Q1 2025.